SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067199
Filing Date
2023-08-14
Accepted
2023-08-14 17:00:55
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_actiniumphar.htm   iXBRL 10-Q 805000
2 CERTIFICATION f10q0623ex31-1_actiniumphar.htm EX-31.1 7748
3 CERTIFICATION f10q0623ex31-2_actiniumphar.htm EX-31.2 7810
4 CERTIFICATION f10q0623ex32-1_actiniumphar.htm EX-32.1 3759
5 CERTIFICATION f10q0623ex32-2_actiniumphar.htm EX-32.2 3737
11 GRAPHIC image_001.jpg GRAPHIC 27849
12 GRAPHIC image_002.jpg GRAPHIC 27179
13 GRAPHIC image_003.jpg GRAPHIC 32141
14 GRAPHIC image_004.jpg GRAPHIC 28425
15 GRAPHIC image_005.jpg GRAPHIC 18718
16 GRAPHIC image_006.jpg GRAPHIC 26113
17 GRAPHIC image_007.jpg GRAPHIC 24924
18 GRAPHIC image_008.jpg GRAPHIC 16821
19 GRAPHIC image_009.jpg GRAPHIC 25398
20 GRAPHIC image_010.jpg GRAPHIC 15246
21 GRAPHIC image_011.jpg GRAPHIC 21593
22 GRAPHIC image_012.jpg GRAPHIC 28374
23 GRAPHIC image_013.jpg GRAPHIC 36999
  Complete submission text file 0001213900-23-067199.txt   4262968

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atnm-20230630.xsd EX-101.SCH 36714
7 XBRL CALCULATION FILE atnm-20230630_cal.xml EX-101.CAL 22214
8 XBRL DEFINITION FILE atnm-20230630_def.xml EX-101.DEF 151124
9 XBRL LABEL FILE atnm-20230630_lab.xml EX-101.LAB 341918
10 XBRL PRESENTATION FILE atnm-20230630_pre.xml EX-101.PRE 165595
54 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_actiniumphar_htm.xml XML 268600
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 231171735
SIC: 2834 Pharmaceutical Preparations